Your browser doesn't support javascript.
loading
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.
Hailemichael, Yared; Dai, Zhimin; Jaffarzad, Nina; Ye, Yang; Medina, Miguel A; Huang, Xue-Fei; Dorta-Estremera, Stephanie M; Greeley, Nathaniel R; Nitti, Giovanni; Peng, Weiyi; Liu, Chengwen; Lou, Yanyan; Wang, Zhiqiang; Ma, Wencai; Rabinovich, Brian; Sowell, Ryan T; Schluns, Kimberly S; Davis, Richard E; Hwu, Patrick; Overwijk, Willem W.
Affiliation
  • Hailemichael Y; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nat Med ; 19(4): 465-72, 2013 Apr.
Article in En | MEDLINE | ID: mdl-23455713
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / CD8-Positive T-Lymphocytes / Cancer Vaccines Limits: Animals Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2013 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / CD8-Positive T-Lymphocytes / Cancer Vaccines Limits: Animals Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2013 Document type: Article Affiliation country: